Consolidated Planning Corp Sells 29 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Consolidated Planning Corp reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,959 shares of the healthcare conglomerate’s stock after selling 29 shares during the quarter. Consolidated Planning Corp’s holdings in UnitedHealth Group were worth $991,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at $30,000. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group during the 3rd quarter valued at $37,000. Friedenthal Financial bought a new position in UnitedHealth Group in the 3rd quarter worth $51,000. Highline Wealth Partners LLC bought a new position in UnitedHealth Group in the 3rd quarter worth $55,000. Finally, Legacy Investment Solutions LLC bought a new position in UnitedHealth Group in the 3rd quarter worth $57,000. 87.86% of the stock is currently owned by institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

NYSE UNH opened at $527.31 on Thursday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company’s 50 day moving average is $526.25 and its two-hundred day moving average is $563.96. The stock has a market cap of $485.27 billion, a price-to-earnings ratio of 34.02, a PEG ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the firm posted $5.83 EPS. The company’s revenue was up 6.8% on a year-over-year basis. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Analyst Upgrades and Downgrades

UNH has been the subject of several research reports. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. UBS Group decreased their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Stephens upped their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Deutsche Bank Aktiengesellschaft upped their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Finally, Truist Financial reduced their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.